Ammonium Chloride → acetic acid 2-(6-tert-butyl-8-fluoro-1-oxo-1H-phthalazin-2-yl)-6-[1-methyl-5-(5-oxetan-3-yl-4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazin-2-ylamino)-6-oxo-1,6-dihydro-pyridazin-3-yl]-benzyl ester

HRID 1431184Notes

Reaction equation

HRID 1431184 reaction equation
[C:1]([O:4][CH2:5][C:6]1[C:11](B2OC(C)(C)C(C)(C)O2)=[CH:10][CH:9]=[CH:8][C:7]=1[N:21]1[N:30]=[CH:29][C:28]2[C:23](=[C:24]([F:35])[CH:25]=[C:26]([C:31]([CH3:34])([CH3:33])[CH3:32])[CH:27]=2)[C:22]1=[O:36])(=[O:3])[CH3:2].Cl[C:38]1[CH:39]=[C:40]([NH:46][C:47]2[CH:59]=[C:50]3[CH2:51][N:52]([CH:55]4[CH2:58][O:57][CH2:56]4)[CH2:53][CH2:54][N:49]3[N:48]=2)[C:41](=[O:45])[N:42]([CH3:44])[N:43]=1.P([O-])([O-])([O-])=O.[K+].[K+].[K+].C1(P(C2CCCCC2)C2C=CC=CC=2C2C(C(C)C)=CC(C(C)C)=CC=2C(C)C)CCCCC1.[Cl-].[NH4+]>C(O)CCC.O>[C:31]([C:26]1[CH:27]=[C:28]2[C:23](=[C:24]([F:35])[CH:25]=1)[C:22](=[O:36])[N:21]([C:7]1[CH:8]=[CH:9][CH:10]=[C:11]([C:38]3[CH:39]=[C:40]([NH:46][C:47]4[CH:59]=[C:50]5[CH2:51][N:52]([CH:55]6[CH2:58][O:57][CH2:56]6)[CH2:53][CH2:54][N:49]5[N:48]=4)[C:41](=[O:45])[N:42]([CH3:44])[N:43]=3)[C:6]=1[CH2:5][O:4][C:1](=[O:3])[CH3:2])[N:30]=[CH:29]2)([CH3:33])([CH3:32])[CH3:34]

Participants

8

Conditions

Temperature
100 °C

Procedure

A solution of 2-(6-tert-butyl-8-fluoro-1-oxophthalazin-2(1H)-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl acetate (249 mg, 0.50 mmol), 6-chloro-2-methyl-4-(5-oxetan-3-yl-4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazin-2-ylamino)-2H-pyridazin-3-one (113 mg, 0.34 mmol), potassium phosphate (178 mg, 0.84 mmol) and dicyclohexyl(2′,4′,6′-triisopropylbiphenyl-2-yl)phosphine (16.0 mg, 0.03 mmol) in butanol (8 ml) and water (2 mL) was flushed with argon before (bis[dibenzylideneacetone]dipalladium) (9.65 mg, 0.02 mmol) was added and the resulting solution heated at 100° C. in for 2 h. The resulting mixture was cooled, poured into a saturated solution of ammonium chloride and extracted with methylene chloride (2×100 mL). The layers were separated and the organic phase dried over magnesium sulfate. The mixture was filtered and concentrated in vacuo. The residue was dissolved in dioxane (10 mL) and treated with a lithium hydroxide solution (0.5 mL, 2.0 M), and the resulting mixture was stirred at room temperature overnight. The resulting mixture was poured into a saturated ammonium chloride solution and extracted with methylene chloride (2×100 mL). The layers were separated and the organic phase dried over magnesium sulfate. The mixture was filtered and concentrated in vacuo. The residue was purified by flash chromatography (silica gel, 24 g, 1% to 10% methanol in dichloromethane) to give acetic acid 2-(6-tert-butyl-8-fluoro-1-oxo-1H-phthalazin-2-yl)-6-[1-methyl-5-(5-oxetan-3-yl-4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazin-2-ylamino)-6-oxo-1,6-dihydro-pyridazin-3-yl]-benzyl ester (113 mg, 54%) as a light yellow solid: mp. 180-185° C.; 1H NMR (300 MHz, DMSO-d6) δ ppm 1.37 (s, 9H) 2.66-2.92 (m, 2H) 3.40-3.83 (m, 6H) 3.98 (t, J=5.48 Hz, 2H) 4.26-4.82 (m, 7H) 6.01 (s, 1H) 7.36-8.00 (m, 6H) 8.50 (d, J=2.64 Hz, 1H) 9.25 (s, 1H).

Workup

  1. additionwas added
  2. temperatureThe resulting mixture was cooled
  3. extractionextracted with methylene chloride (2×100 mL)
  4. customThe layers were separated
  5. dry with materialthe organic phase dried over magnesium sulfate
  6. filtrationThe mixture was filtered
  7. concentrationconcentrated in vacuo
  8. dissolutionThe residue was dissolved in dioxane (10 mL)
  9. additiontreated with a lithium hydroxide solution (0.5 mL, 2.0 M)
  10. additionThe resulting mixture was poured into a saturated ammonium chloride solution
  11. extractionextracted with methylene chloride (2×100 mL)
  12. customThe layers were separated
  13. dry with materialthe organic phase dried over magnesium sulfate
  14. filtrationThe mixture was filtered
  15. concentrationconcentrated in vacuo
  16. customThe residue was purified by flash chromatography (silica gel, 24 g, 1% to 10% methanol in dichloromethane)

Sources & evidence

ORD record
ord-4eb3740cbe4e4d1580306aef81eb92fd
Source dataset
uspto-grants-2015_01
Patent number
US08940741B2

Reaction notes

Loading…